Erytech Pharma SA (ERYP.OQ)
ERYP.OQ on NASDAQ Stock Exchange Global Select Market
Change (% chg)
Revenue & Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Performance for Erytech Pharma SA
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Erytech Pharma announces pricing of global offering of 5.4 mln new ordinary shares
- BRIEF-Erytech Pharma announces trading suspension of its ordinary shares on Euronext paris
- BRIEF-Erytech Pharma 9M net loss widens to 20.8 million euros
- BRIEF-Erytech Pharma sees U.S. IPO of up to 4.26 mln ordinary shares in form of ADSs
- BRIEF-Erytech Pharma announces resubmission of european marketing authorization application for GRASPA
|% Shares Owned:||26.32%|
|# of Holders:||1|
|Total Shares Held:||3,090,069|
|3 Mo. Net Change:||3,090,069|
|# New Positions:||1|
|# Closed Positions:||0|
|# Increased Positions:||1|
|# Reduced Positions:||0|
|# Net Buyers:||1|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.